John Lunger's most recent trade in Adaptimmune Therapeutics Plc - ADR was a trade of 1,612,032 Option to purchase Ordinary Shares done . Disclosure was reported to the exchange on Feb. 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adaptimmune Therapeutics P... | John Lunger | Chief Patient Supply Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 1,612,032 | 1,612,032 | - | - | Option to purchase Ordinary Shares | |
| Adaptimmune Therapeutics P... | John Lunger | Chief Patient Supply Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 1,074,696 | 1,074,696 | - | - | Option to purchase Ordinary Shares | |
| Adaptimmune Therapeutics P... | John Lunger | Chief Patient Supply Officer | Sale of securities on an exchange or to another person at price $ 0.58 per share. | 17 Jan 2025 | 5,584 | 7,510 (0%) | 0% | 0.6 | 3,243 | American Depositary Shares representing Ordinary Shares |
| Adaptimmune Therapeutics P... | John Lunger | Chief Patient Supply Officer | Sale of securities on an exchange or to another person at price $ 0.57 per share. | 13 Jan 2025 | 9,803 | 13,756 (0%) | 0% | 0.6 | 5,635 | American Depositary Shares representing Ordinary Shares |
| Adaptimmune Therapeutics P... | John Lunger | Chief Patient Supply Officer | Sale of securities on an exchange or to another person at price $ 0.59 per share. | 13 Jan 2025 | 5,471 | 7,623 (0%) | 0% | 0.6 | 3,216 | American Depositary Shares representing Ordinary Shares |
| Adaptimmune Therapeutics P... | John Lunger | Chief Patient Supply Officer | Sale of securities on an exchange or to another person at price $ 0.59 per share. | 13 Jan 2025 | 4,268 | 5,845 (0%) | 0% | 0.6 | 2,509 | American Depositary Shares representing Ordinary Shares |
| Adaptimmune Therapeutics P... | John Lunger | Chief Patient Supply Officer | Sale of securities on an exchange or to another person at price $ 0.67 per share. | 16 Jan 2024 | 12,805 | 19,015 (0%) | 0% | 0.7 | 8,618 | American Depositary Shares representing Ordinary Shares |
| Adaptimmune Therapeutics P... | John Lunger | Chief Patient Supply Officer | Sale of securities on an exchange or to another person at price $ 0.67 per share. | 16 Jan 2024 | 5,309 | 7,785 (0%) | 0% | 0.7 | 3,573 | American Depositary Shares representing Ordinary Shares |
| Adaptimmune Therapeutics P... | John Lunger | Chief Patient Supply Officer | Sale of securities on an exchange or to another person at price $ 0.79 per share. | 16 Jan 2024 | 4,681 | 7,023 (0%) | 0% | 0.8 | 3,698 | American Depositary Shares representing Ordinary Shares |
| Adaptimmune Therapeutics P... | John Lunger | Chief Patient Supply Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2024 | 2,544,432 | 2,544,432 | - | - | Option to purchase Ordinary Shares | |
| Adaptimmune Therapeutics P... | John Lunger | Chief Patient Supply Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2024 | 565,416 | 565,416 | - | - | Option to purchase Ordinary Shares | |
| Adaptimmune Therapeutics P... | John Lunger | Chief Patient Supply Officer | Sale of securities on an exchange or to another person at price $ 0.85 per share. | 11 Jan 2024 | 5,220 | 7,874 (0%) | 0% | 0.9 | 4,458 | American Depositary Shares representing Ordinary Shares |
| Adaptimmune Therapeutics P... | John Lunger | Chief Patient Supply Officer | Sale of securities on an exchange or to another person at price $ 0.84 per share. | 11 Jan 2024 | 4,009 | 6,104 (0%) | 0% | 0.8 | 3,354 | American Depositary Shares representing Ordinary Shares |